Ceeli Thairianathan: Bridging Biotechnology and Clinical Application
Ceeli Thairianathan, Northeastern Graduate Student, shared a post on LinkedIn:
“Bridging Biotechnology and Clinical Application: Key Insights from Biocytogen
As a biotechnology graduate student, I recently attended a webinar by Biocytogen on the critical role of humanized models in navigating the complexities of cardio-metabolic drug discovery.
Here is a concise technical summary of the platform’s capabilities:
1. Next-Gen Anticoagulation:
Biocytogen is utilizing B-hFXI and B-hFXII plus mice to target the intrinsic coagulation pathway.
This strategy aims to uncouple dangerous thrombosis from essential physiological hemostasis.
2. Precision Cardiomyopathy Models:
The B-Mybpc3 KO model demonstrates high phenotypic fidelity to human disease, exhibiting cardiac enlargement and ventricular wall thickening.
Masson-staining in 17-week-old models provides clear evidence of endocardial collagen fiber proliferation.
3. Systemic Metabolic Solutions:
Advanced multi-target models, such as the B-hLPA/hAPOB/hPCSK9 plus mice, are engineered to evaluate therapies for atherosclerosis and hyperlipidemia.
The broader portfolio addresses NAFLD/MASH, Hyperuricemia, and Diabetic Nephropathy.
4. Integrated Assay Platform:
Beyond the models, Biocytogen provides a robust analytical framework including MSD, FACS, and Luminex to support comprehensive PK/PD/Tox/MoA studies.
These integrated preclinical solutions are essential for accelerating the transition from laboratory research to successful IND filing.
I am grateful for the expert insights shared during this session, which underscored the importance of humanized precision in modern drug discovery.”
Stay updated with Hemostasis Today.
-
May 2, 2026, 05:24Aaron Kantambo: The Thrombocytic Lineage in Hemostasis and Vascular Repair
-
May 2, 2026, 05:23Ali AlBahar: Ensuring Safety and Precision Across the Blood Transfusion Process
-
May 1, 2026, 17:55Salih Ehsan: The Deceptive Nature of B12 Deficiency Not Just Anemia
-
May 1, 2026, 17:45Angela Blue: Insurance Education as a Tool for Strengthening Patient Communities
-
May 1, 2026, 17:36Smitirupa Mishra: Hematology Formulas Made Simple, Structured, And Useful For Everyday Clinical Practice
-
May 1, 2026, 17:00Frank Weinz: VTE Prevention Strategies and Advances in Clinical Practice
-
May 1, 2026, 16:54Pierre François Sabouret: Women’s Health Should Be a Priority for All HCPs, Not Just WIC
-
May 1, 2026, 16:44Jean Jacques Kiladjian: A Global Triumph in MPN Research at ESHMPN 2026
-
May 1, 2026, 16:36Shek Sady Khan: VTE as a Major Yet Underrecognized Cause of Preventable Morbidity and Mortality